| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/24/2009 | US7494969 a plant-derived protein with anti-cancer properties which binds the human growth hormone-releasing hormone (hGHRH). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, is particularly adapted for preparing a medicament that is intended for the treatment of cancers for which growth |
| 02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
| 02/24/2009 | US7494807 Nutrient broth for propagation of hematopoietic stem cells |
| 02/24/2009 | US7494804 Polynucleotide encoding cytokine receptor zcytor17 multimer |
| 02/24/2009 | US7494767 Assay for TSG101 as inhibitors of HIV production |
| 02/24/2009 | US7494669 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 02/24/2009 | US7494664 Hydroxyapatite, collagen, alginate; microporous structures in which c-axis of hydroxyapatite is oriented along collagen fibers; mechanical properties similar to those of natural bones, excellent bioadaptability and bone-conductivity; artificial bones, joints, cements for tendons and bones,dental implants |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | US7494660 HCV NS3-NS4A protease resistance mutants |
| 02/24/2009 | US7494654 Compositions and methods for treating cardiovascular conditions with botulinum toxin |
| 02/24/2009 | US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen |
| 02/24/2009 | US7494652 polyclonal antibodies comprising tumor necrosis factor, b-cell differentiation factor and interferon antibodies, directed to cytokines, used for treatment of septic shock in animals, including humans |
| 02/24/2009 | US7494646 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 02/24/2009 | US7494645 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries |
| 02/24/2009 | CA2443543C Supplementation of equine feedstuffs |
| 02/24/2009 | CA2415364C Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/24/2009 | CA2354472C Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 02/24/2009 | CA2308462C Fibrin sealants or adhesives comprising a hyaluronic acid derivative material |
| 02/24/2009 | CA2262582C Hcg and derivatives as matrix metalloproteases inhibitors |
| 02/24/2009 | CA2247820C Functionalized nanotubes |
| 02/24/2009 | CA2245497C Peptide immunogens for vaccination against and treatment of allergy |
| 02/24/2009 | CA2219455C Use of pyrrolidine derivatives for treating alcoholism |
| 02/24/2009 | CA2214633C Antibody purification by low-ph hydrophobic interaction chromatography |
| 02/24/2009 | CA2194236C Helicobacter proteins and vaccines |
| 02/24/2009 | CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 02/24/2009 | CA2174556C Recombinant p53 adenovirus methods and compositions |
| 02/21/2009 | CA2638970A1 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/20/2009 | CA2597972A1 Method and composition for treating diabetes |
| 02/20/2009 | CA2597954A1 Method and composition for repairing heart tissue |
| 02/19/2009 | WO2009023636A1 Novel insect cadherin fragments |
| 02/19/2009 | WO2009023601A2 Apparatus and methods for treating epilepsy using convection-enhanced delivery |
| 02/19/2009 | WO2009023416A2 Cosmetic methods and compositions for repairing human skin |
| 02/19/2009 | WO2009023332A2 Device and method for purifying virally infected blood |
| 02/19/2009 | WO2009023306A2 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens |
| 02/19/2009 | WO2009023270A2 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/19/2009 | WO2009022988A2 Vhz for diagnosis and treatment of cancer |
| 02/19/2009 | WO2009022907A2 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 02/19/2009 | WO2009022898A1 A composition based on perhydrosqualene and collagen-polyvinylpyrrolidone for filling minor cutaneous depressions |
| 02/19/2009 | WO2009022854A1 Composition for regulating cell death comprising asb-9 protein and asb-9 socs protein |
| 02/19/2009 | WO2009022340A1 Peptides and pharmaceutical compositions for treating connective tissue |
| 02/19/2009 | WO2009022338A2 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
| 02/19/2009 | WO2009022182A1 Depsipeptide derivatives and their therapeutic use |
| 02/19/2009 | WO2009022068A2 Medicament for treating parkinson's disease |
| 02/19/2009 | WO2009022067A2 Medicament for treating parkinson's disease |
| 02/19/2009 | WO2009022013A1 Insulin analogues with an acyl and aklylene glycol moiety |
| 02/19/2009 | WO2009022005A1 Insulin analogues with an acyl and alkylene glycol moiety |
| 02/19/2009 | WO2009021971A2 Novel targets and compounds for therapeutic intervention of hiv infection |
| 02/19/2009 | WO2009021955A1 Rapid acting insulin analogues |
| 02/19/2009 | WO2009021926A2 Use of a neurotoxin |
| 02/19/2009 | WO2009021704A1 Repair of lesions in cartilage and bone using a chondro-regulative matrix |
| 02/19/2009 | WO2009021322A1 Tumor cell-derived microvesicles |
| 02/19/2009 | WO2009021293A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity |
| 02/19/2009 | WO2009021289A1 Potassium channel inhibitors |
| 02/19/2009 | WO2009021254A1 Treatment of atherosclerosis |
| 02/19/2009 | WO2009009378A3 Cathepsin-d neuroprotection |
| 02/19/2009 | WO2009005579A9 High affinity fluorochrome binding peptides |
| 02/19/2009 | WO2008157369A3 Use of taci-ig fusion protein such as atacicept for the manufacture of a medicament for treating lupus erythematosus |
| 02/19/2009 | WO2008156644A3 Stat modulators |
| 02/19/2009 | WO2008155509A3 Modified human factor vii/viia and pharmaceutical composition containing same |
| 02/19/2009 | WO2008151637A3 Neuroplastin derived peptides |
| 02/19/2009 | WO2008150896A3 P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH β-1 INTEGRIN ACTIVATION |
| 02/19/2009 | WO2008148932A3 Glycosylasparaginase for treatment of cancers or inflammatory diseases |
| 02/19/2009 | WO2008142517A3 Synthetic peptide having anti-inflammatory and anti-microbic properties |
| 02/19/2009 | WO2008142319A3 Peptide analogues of melanocortin receptors |
| 02/19/2009 | WO2008139238A3 Use of the augmenter of liver regeneration protein as an apoptosis regulator |
| 02/19/2009 | WO2008133908A3 Suspension formulations of insulinotropic peptides and uses thereof |
| 02/19/2009 | WO2008133789A4 Methods and compositions for targeting afap |
| 02/19/2009 | WO2008131746A3 Means for preventative anti-infective treatment of a patient |
| 02/19/2009 | WO2008127285A3 Target peptides for ovarian cancer immunotherapy |
| 02/19/2009 | WO2008118332A3 Hydrazido-peptides as inhibitors of hcv ns3-protease |
| 02/19/2009 | WO2008106694A3 Systems, methods and compositions for optical stimulation of target cells |
| 02/19/2009 | WO2008088422A3 Toxin peptide therapeutic agents |
| 02/19/2009 | WO2008079672A4 Flowable carrier compositions for orthopedic implants and methods of use |
| 02/19/2009 | US20090048302 Methods and compositions for the treatment of conditions related to gastric acid secretion |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048183 Iap binding compounds |
| 02/19/2009 | US20090048182 Cosmetic Use of at Least One Natural Ac-N-Ser-Asp-Lys-Pro-Tetrapeptide or One of Its Analogues as Agent for Slowing Down Loss of Hair and/or Stimulating Hair Growth |
| 02/19/2009 | US20090048181 Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis |
| 02/19/2009 | US20090048180 Sustained-release preparation |
| 02/19/2009 | US20090048179 Use of 5-phosphodiesterase inhibitors to enhance the permeability of the blood-brain barrier of abnormal brain tissue and the blood-tumor barrier |
| 02/19/2009 | US20090048178 Lps or lipid a binding agent and novel peptide |
| 02/19/2009 | US20090048177 Methods for the treatment of mood disorders |
| 02/19/2009 | US20090048176 Antibacterial agent |
| 02/19/2009 | US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/19/2009 | US20090048174 Methods for inhibiting angiogenesis and tumor growth by inhibition of beta or delta protein kinase C |
| 02/19/2009 | US20090048173 Use Of Dipyridamole For Treatment Of Resistance To Platelet Inhibitors |
| 02/19/2009 | US20090048172 Neuroprotective dietary supplement |
| 02/19/2009 | US20090048171 Treatment of viral infections |
| 02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
| 02/19/2009 | US20090048169 Identification of Crmp4 as a Convergent Regulator of Axon Outgrowth Inhibition |
| 02/19/2009 | US20090048168 Inhibitors of bcl-2 |
| 02/19/2009 | US20090048167 Disease treatment via antimicrobial peptides or their inhibitors |
| 02/19/2009 | US20090048166 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists |
| 02/19/2009 | US20090048165 Anti-hiv agent |
| 02/19/2009 | US20090048164 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| 02/19/2009 | US20090048163 Nucleic acid and protein sequences of asporins |
| 02/19/2009 | US20090048162 Methods of treating neuronal disorders using mntf peptides and analogs thereof |
| 02/19/2009 | US20090048161 Cytokine receptor modulators and uses thereof |